Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9fa583464a942685638c5f8464cd37b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d77230e6ef81f3f2c8ba316036b4e6aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fe993f033ca24099f9e9b93cfebc45e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adb0e564374fedf34b36103d36e6455a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_942de7702183f2b21151d080fc93357c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D201-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-10 |
filingDate |
2009-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef2bf2195d154ea84c157a84471bc953 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a234eca67625186fa8e08082c2498164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff1f8770a496e0d2afd4255c70ecf2d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_330ed8870209f528bc0c06dd99db7368 |
publicationDate |
2014-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8673599-B2 |
titleOfInvention |
Preparation of 6-aminocaproic acid from 5-formylvaleric acid |
abstract |
The invention relates to a method for preparing 6-aminocaproic acid (hereinafter also referred to as ‘6-ACA’) using a biocatalyst. The invention further relates to a method for preparing e-caprolactam (hereafter referred to as ‘caprolactam’) by cyclising such 6-ACA. The invention further relates to a host cell, a micro-organism, or a polynucleotide which may be used in the preparation of 6-ACA or caprolactam. |
priorityDate |
2008-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |